Description du projet
Chirurgie oculaire assistée par robot guidée par l’IA
Les maladies de la rétine représentent la principale cause de lésions visuelles dans les pays industrialisés et constituent un problème de santé publique de plus en plus préoccupant. La réalisation d’actes chirurgicaux directement sur la rétine à l’aide d’instruments microchirurgicaux ultrafins et avec une vue restreinte est un opération très délicate qui nécessite des chirurgiens hautement qualifiés et expérimentés. Le projet GEYEDANCE, financé par l’UE, introduira des méthodes d’intelligence artificielle dans la robotique chirurgicale afin d’apporter un soutien avancé aux utilisateurs et de soulager la charge mentale et physique du chirurgien. GEYEDANCE mettra au point une technologie tangible et «proche d’une certification» et mènera un premier essai clinique. À terme, GEYEDANCE aidera les chirurgiens de la rétine à optimiser leurs opérations et contribuera à améliorer les résultats chirurgicaux au bénéfice des patients de demain.
Objectif
"Retina indications are the leading cause of visual impairment in industrialized countries and posing a big unmet socio-economic challenge. Performing surgical actions directly at the retina - one of the most delicate and sensitive areas of the human body - with ultra-thin microsurgical instruments and with a limited view makes retina surgery a very challenging discipline with surgeons working at the limit of what is possible, requiring years of training and experience to reach proficiency.
The GEYEDANCE project is directly addressing this need by translating methods from Artificial Intelligence to the area of surgical robotics, together to be used for an advanced user support for reducing the mental and physical load of the surgeon. Work in the project is building on two existing main blocks - the CE certified robot platform PSS from project partner Preceyes, and a prototype for a Common-Path OCT system with extended measurement depth from partner ACMIT. For the AI-components to be developed, two European leading groups in this domain - ALTAIR/University of Verona and ARTORG/University of Bern - are part of the consortium. Seamless involvement of key stakeholders during the complete development phase is indispensable for a meaningful outcome, and thus a prominent board of world-wide leading eye surgeons, led by partner University of Ferrara, will provide user insight and evaluate the resulting advanced robotic solution. Development and validation of the GEYEDANCE system is strongly supported by industrial partners Carl Zeiss AG and Carl Zeiss Meditec AG.
In-line with the concept of the “Innovation Actions” instrument, the project aims to generate tangible and “close-to-certification"" technology reaching a TRL of 7 (or even higher), being evaluated in the framework of a first clinical trial. All together, the planned AI-based guidance system GEYEDANCE will help the consortium to further consolidate their leading position worldwide, will help retinal surgeons to optimize their task, and finally will help the patient by contributing to a better surgical outcome."
Champ scientifique
- natural sciencescomputer and information sciencesartificial intelligence
- medical and health sciencesclinical medicinesurgery
- medical and health sciencesclinical medicineophthalmology
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringrobotics
Mots‑clés
Programme(s)
Régime de financement
HORIZON-IA - HORIZON Innovation ActionsCoordinateur
2700 Wiener Neustadt
Autriche
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.